Navigation Links
Harvard scientists solve mystery about why HIV patients are more susceptible to TB infection
Date:6/30/2009

A team of Harvard scientists has taken an important first step toward the development of new treatments to help people with HIV battle Mycobacterium tuberculosis (TB) infection. In their report, appearing in the July 2009 print issue of the Journal of Leukocyte Biology (http://www.jleukbio.org) they describe how HIV interferes with the cellular and molecular mechanisms used by the lungs to fight TB infection. This information is crucial for researchers developing treatments to help people with HIV prevent or recover from TB infection.

"HIV/TB co-infection is a critical global health problem, especially in developing countries," said Naimish Patel, M.D., lead researcher on the study and Instructor of Medicine at Beth Israel Deaconess Medical Center and Harvard Medical School. "We hope that these findings will lead to further studies and possible new therapies for treating or preventing tuberculosis in HIV disease."

Patel and colleagues made their discovery by extracting immune cells called "alveolar macrophages" from the lungs of otherwise healthy, asymptomatic HIV-positive patients as well as from people who did not have HIV. In people who are HIV-positive, the macrophages have a decreased response to the TB bacterium when compared to people who did not have HIV. To learn why, the scientists examined lung specimens from the HIV-positive patients and found increased levels of a molecule called IL-10, which elevated the amount of a protein called "BCL-3" in alveolar macrophages and that reduced their ability to ward off TB infection.

"HIV and TB represent two of the most significant health challenges in human history and the combination of the two infections is particularly devastating because HIV dramatically increases the severity of TB infection," said John Wherry, Ph.D., Deputy Editor of the Journal of Leukocyte Biology, "There are still many unknowns about how HIV reduces the ability of the body to combat other infections. This study sheds light on co-infection with HIV and TB, which up to this point, has perplexed scientists and physicians alike."


'/>"/>

Contact: Cody Mooneyhan
cmooneyhan@faseb.org
301-634-7104
Federation of American Societies for Experimental Biology
Source:Eurekalert

Related biology news :

1. Duke, Harvard researchers to monitor bonobo reintroduction
2. Harvard scientist says we are what we eat -- and what we cook
3. Organizational Change Management for Sustainability: The Harvard Case Study
4. Eli and Edythe L. Broad make unprecedented gift to endow Broad Institute of Harvard & MIT
5. Wearable Sensors Conceived at Harvard Robotics Lab Measure Hand Forces
6. New discoveries from Harvard and Baylor get to the heart of cardiovascular disease
7. Jeremy Jackson honored by Harvard Museum of Natural History
8. Harvard researchers publish MRI images of genes in action in the living brain
9. BASF and Harvard University announce extensive research collaboration
10. Scripps Research scientists observe human neurodegenerative disorder in fruit flies
11. CSHL scientists harness logic of Sudoku math puzzle to vastly enhance genome-sequencing capability
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/15/2016)... DUBLIN , Nov 15, 2016 Research ... - Global Forecast to 2021" report to their offering. ... ... reach USD 16.18 Billion by 2021 from USD 6.21 Billion in ... Growth of the bioinformatics market is driven by ...
(Date:6/27/2016)... DUBLIN , June 27, 2016 Research ... in North America 2016-2020" report to their offering. ... North America to grow at a CAGR ... has been prepared based on an in-depth market analysis with inputs ... growth prospects over the coming years. The report also includes a ...
(Date:6/22/2016)... On Monday, the Department of Homeland Security ... solutions for the Biometric Exit Program. The Request for ... (CBP), explains that CBP intends to add biometrics to ... United States , in order to deter visa ... Logo - http://photos.prnewswire.com/prnh/20160622/382209LOGO ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... to fuel Philadelphia,s innovative digital ... Southeastern Pennsylvania (" Ben Franklin "); Independence ... Cross; and Safeguard Scientifics ("Safeguard") (NYSE: SFE ... funding initiative over a four year period to grow ... burgeoning economic vitality in digital health, Ben Franklin ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... ... from its phase I/II dose escalation and expansion clinical trial for its lead ... Vienna, Austria. The purpose of the trial was to determine the safety, antitumor ...
(Date:12/7/2016)... , ... December 07, 2016 , ... ... today announced that it has become a Wonderware Certified System Integrator Partner. ... Partner by Schneider Electric Software. , “The System Integrator Partner certification gives customers ...
(Date:12/7/2016)... 7, 2016 /PRNewswire/ - OncoQuest Inc. ("OncoQuest"), a ... of immunotherapeutic products for the treatment of cancer, ... Antibody Manufacturing Development Program with Cytovance Biologics ( ... its oregovomab antibody product. Supported by recent positive ... study in ovarian cancer patients, OncoQuest has engaged ...
Breaking Biology Technology: